Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05573074 · ClinicalTrials.gov registry record · NA
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
A NA study of Major Depressive Disorder, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 3
- Study locations
NCT05573074 is a NA study of Major Depressive Disorder that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 120 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (68% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05573074, a NA study of Major Depressive Disorder, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research study is to determine if application of near infrared energy to the forehead can change blood flow in the brains of people with depression. Near infrared energy is like light but is not visible to the human eye.
Conditions Studied
Interventions
- DEVICE Sham
- DEVICE Transcranial Photobiomodulator
Study Locations (3)
New York
- NYU Langone Health - New York
- Nathan Kline Institute for Psychiatric Research - Orangeburg
Massachusetts
- Harvard Medical School - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05573074
The ClinicalTrials.gov registry entry for NCT05573074 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (68% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.
NCT05573074 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05573074 about?
NCT05573074 is a clinical study titled "Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33". The purpose of this research study is to determine if application of near infrared energy to the forehead can change blood flow in the brains of people with depression. Near infrared energy is like light but is not visible to the human eye.
What is the current status of trial NCT05573074?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-04-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05573074 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
What interventions are being tested in trial NCT05573074?
The interventions under investigation include: Sham (DEVICE), Transcranial Photobiomodulator (DEVICE).
Who is sponsoring clinical trial NCT05573074?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05573074 being conducted?
This trial has 3 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.